3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
Obesity
4
Sarcopenia
3
Polycystic Ovary Syndrome
3
Neoplasms
3
Melanoma
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Malnutrition
2
Lymphoma, Follicular
2
Colorectal Neoplasms
2
Breast Carcinoma In Situ
2
Wound Infection
1
Weight Loss
1
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Psoriasis
1
Precancerous Conditions
1
Postoperative Complications
1
Polyps
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Paget's Disease, Mammary
1
Overweight
1
Osteoarthritis
1
Olfaction Disorders
1
Non-alcoholic Fatty Liver Disease
1
Interventions
tofacitinib
7
Etanercept
6
Methotrexate
3
Adalimumab
3
secukinumab
2
Nivolumab
2
sotrastaurin
1
sodium luminolate
1
ixekizumab
1
deucravacitinib
1
calcipotriene
1
cabozantinib
1
baricitinib
1
apremilast
1
abrocitinib
1
Vitamin D
1
Vaccines
1
Specimen Handling
1
Saline Solution
1
Platinum Compounds
1
Ipilimumab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Psoriasis
×
Docosahexaenoic Acids
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts